2,Alpha-DMT
Jump to navigation
Jump to search
| File:2,a-DMT.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| Chemical and physical data | |
| Formula | C12H16N2 |
| Molar mass | 188.27 g·mol−1 |
2,alpha-DMT, or 2,a-dimethyltryptamine, is a lesser-known psychedelic drug. It is the 2,a-dimethyl analog of DMT. 2,a-DMT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), Shulgin lists the dosage as 300-500 mg, and the duration as 7-10 hours.[1] 2,a-DMT causes mydriasis and tingling. It also produces a calm, drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,a-DMT.
References
External links
Categories:
- Articles with short description
- Pages with broken file links
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Psychedelic tryptamines